Given that a more advanced TNM stage, positive lymph node metastasis, and distant metastasis are adverse prognostic features, the present results may explain why positive p53 expression is associated with poor 5-year survival in patients with EC. This evidence concerns the gene TP53 and metastatic malignant neoplasm in the lymph nodes.